Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Leukotrienes: New Concepts and Targets for Therapy
Type
Physical Book
Publisher
Language
Inglés
Pages
143
Format
Paperback
Dimensions
23.4 x 15.6 x 0.8 cm
Weight
0.23 kg.
ISBN13
9789401060455

Leukotrienes: New Concepts and Targets for Therapy

Rodger, Ian ; Botting, Jack H. ; Dahlén, Sven-Erik (Author) · Springer · Paperback

Leukotrienes: New Concepts and Targets for Therapy - Rodger, Ian ; Botting, Jack H. ; Dahlén, Sven-Erik

New Book

£ 176.72

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Friday, August 09 and Wednesday, August 21.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Leukotrienes: New Concepts and Targets for Therapy"

In the two decades since the elusive "slow reacting substance of anaphylaxis" (SRS-A) was identified as a product of the action of the 5-lipoxygenase enzyme on arachidonic acid, it has been well established that the leukotrienes are key mediators of both alIergy and inflammation. Their release by alIergen or other challenge has been demonstrated in the lungs of asthmatic subjects, and measurement of urinary leukotriene concentrations in such patients has been shown to be a valuable, non- invasive indicator. Significant progress has been made towards the characterization of the leukotriene receptor subtypes, exemplified by the cloning of the LTB4 receptor earlier this year. Coupled with this there has been a continued elucidation of signal transduction mechanisms underlying receptor activation. Consequent upon these advances has been the development of potent antagonists of the CysLT receptor, J and both these and inhibitors of leukotriene biosynthesis have entered clinical practice in the therapy of asthma. In this clinical setting antagonists of the CysLTJ receptor have been shown to be an effective therapy in chronic asthmatics, against antigen- and exercise-induced bronchoconstriction, and in aspirin-intolerant asthmatics. The advent of this new class of agents promises to change the way in which asthmatic patients are currently treated.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews